Abstract:Cyclin A is required for cell cycle S phase entry, and its overexpression contributes to tumorigenesis. Release of pre-existing E2Fs from inactive complexes of E2F and hypophosphorylated retinoblastoma (RB) is the prevailing dogma for E2F transcriptional activation of target genes such as cyclin A. Here we explored the hypothesis that new synthesis of E2F-1 is required for insulin-like growth factor-I (IGF-I) to induce cyclin A accumulation and RB hyperphosphorylation, events that are targeted by tumor necrosis factor alpha (TNFalpha) to arrest cell cycle progression. We first established that IGF-I increases expression of cyclin A, causes hyperphosphorylation of RB, and augments the mass of E2F-1 in a time-dependent manner. As expected, E2F-1 small interfering RNA blocks the ability of IGF-I to increase synthesis of E2F-1. Most important, this E2F-1 small interfering RNA also blocks the ability of IGF-I to increase cyclin A accumulation and to hyperphosphorylate RB. We next established that TNFalpha dose-dependently inhibits IGF-I-induced phosphorylation of both RB and histone H1 by cyclin A-dependent cyclin-dependent kinases. Cyclin-dependent kinase 2 (Cdk2) mediates this suppression because co-immunoprecipitation experiments revealed that TNFalpha reduces the amount of IGF-I-induced cyclin A that binds Cdk2, leading to a reduction in Cdk2 enzymatic activity. TNFalpha antagonizes the ability of IGF-I to increase mass of both E2F-1 and cyclin A but not cyclin E or D1. The cytostatic property of TNFalpha is also shown by its ability to block IGF-I-stimulated luciferase activity of a cyclin A promoter reporter. Deletion of an E2F recognition site from this reporter eliminates the regulatory effects of both IGF-I and TNFalpha on cyclin A transcription, indicating the essential role of E2F-1 in mediating their cross-talk. Collectively, these results establish that TNFalpha targets IGF-I-induced E2F-1 synthesis, leading to inhibition of the subsequent accumulation in cyclin A, formation of cyclin A-Cdk2 complexes, hyperphosphorylation of RB, and cell cycle arrest.

Insulin-like Growth Factor-1 Promotes Cell Cycle Progression Via Upregulation of Cyclin D1 Expression Through the Phosphatidylinositol 3-Kinase/nuclear Factor-Κb Signaling Pathway in FRTL Thyroid Cells

Role of Insulin-Like Growth Factor-1 (IGF-1) in Regulating Cell Cycle Progression

Tumor Necrosis Factor Α Inhibits Cyclin A Expression and Retinoblastoma Hyperphosphorylation Triggered by Insulin-like Growth Factor-I Induction of New E2F-1 Synthesis

Thyroid hormone-mediated growth and differentiation of growth plate chondrocytes involves IGF-1 modulation of β-catenin signaling

Role of Insulin-Like Growth Factor 1 in Drug Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer

Effects of IGF-II on promoting proliferation and regulating nitric oxide synthase gene expression in mouse osteoblast-like cell

Expression and significance of IGF-1 and IGF-1R in thyroid nodules

Effects of Insulin-Like Growth Factor-1 on the Proliferation, Apoptosis and MAPK Signaling Pathway of Rat Colonic Smooth Muscle Cells

Prostaglandin E2 and insulin-like growth factor I interact to enhance proliferation of theca externa cells from chicken prehierarchical follicles

Insulin Analogs Detemir, Glargine And Lispro Enhance Proliferation Of Human Thyroid And Gastric Normal Or Cancer Cell Lines

Cell cycle control by the insulin-like growth factor signal: at the crossroad between cell growth and mitotic regulation

Effects of diosgenin on cell proliferation induced by IGF-1 in primary human thyrocytes

Insulin-Like Growth Factor-I Provokes Functional Antagonism and Internalization of Β1-Adrenergic Receptors

Functional Significance of Type 1 Insulin-like Growth Factor-mediated Nuclear Translocation of the Insulin Receptor Substrate-1 and Β-Catenin

High Iodine Induces the Proliferation of Papillary and Anaplastic Thyroid Cancer Cells via AKT/Wee1/CDK1 Axis

Alterations in tyrosine kinase receptor (Trk) expression induced by insulin-like growth factor-1 in cultured dorsal root ganglion neurons.

Insulin-like Growth Factor-1 Induces the Phosphorylation of PRAS40 Via the PI3K/Akt Signaling Pathway in PC12 Cells.

Insulin-Like Growth Factor 1 Receptor Promotes the Growth and Chemoresistance of Pancreatic Cancer

Direct Cell Cycle Regulation By The Fibroblast Growth Factor Receptor (Fgfr) Kinase Through Phosphorylation-Dependent Release Of Cks1 From Fgfr Substrate 2

Insulin-like Growth Factor-1 Inhibits the Apoptosis of Rat Gastric Smooth Muscle Cells Cultured under High Glucose Condition Through PI3K-Akt-PKC-Ca2+pathway

Effects of Insulin Analogs and Glucagon-Like Peptide-1 Receptor Agonists on Proliferation and Cellular Energy Metabolism in Papillary Thyroid Cancer